NCT02870348View on ClinicalTrials.gov

Long-term Safety of Alpha1-Proteinase Inhibitor (Human) in Japanese Subjects With Alpha1 Antitrypsin Deficiency (GTI1401-OLE)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

July 29, 2016

Primary Completion Date

February 16, 2021

Study Completion Date

February 16, 2021

Conditions
Alpha1-Antitrypsin Deficiency
Interventions
BIOLOGICAL

Alpha-1 MP

Alpha-1 MP is a stable, sterile, lyophilized preparation of human alpha1-PI, also known as alpha1-antitrypsin.

Trial Locations (3)

036-8563

Hiroskai University Hospital, Aomori

060-8648

Hokkaido University Hospital, Hokkaido

113-8431

Juntendo University Hospital, Tokyo

Sponsors
All Listed Sponsors
collaborator

Grifols Japan K.K.

OTHER

lead

Grifols Therapeutics LLC

INDUSTRY